Product Details for NDA 017634
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE)
5GM/100ML;75MG/100ML
Marketing Status: Prescription
5GM/100ML;150MG/100ML
Marketing Status: Prescription
5GM/100ML;224MG/100ML
Marketing Status: Prescription
5GM/100ML;300MG/100ML
Marketing Status: Prescription
5GM/100ML;75MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE)
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;150MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE)
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;224MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017634
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (DEXTROSE; POTASSIUM CHLORIDE)
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017634
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
5GM/100ML;300MG/100ML
Marketing Status: Prescription
Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N017634
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status: Prescription
Patent and Exclusivity Information